Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of FXYD2 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of FXYD2 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic affects the expression of FXYD2 mRNA | affects expression | 18414638
|
D001464 |
Barium |
Barium results in decreased activity of FXYD2 protein | decreases activity | 11533133
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of FXYD2 mRNA | increases expression | 20106945
|
C002791 |
bismuth tripotassium dicitrate |
bismuth tripotassium dicitrate results in increased expression of FXYD2 mRNA | increases expression | 15912405
|
D002118 |
Calcium |
Calcium inhibits the reaction [FXYD2 protein results in increased transport of Deoxyglucose] | decreases reaction|increases transport | 11533133
|
D002118 |
Calcium |
Calcium inhibits the reaction [FXYD2 protein results in increased transport of Inulin] | decreases reaction|increases transport | 11533133
|
D002118 |
Calcium |
Calcium results in decreased activity of FXYD2 protein | decreases activity | 11533133
|
D003847 |
Deoxyglucose |
Calcium inhibits the reaction [FXYD2 protein results in increased transport of Deoxyglucose] | decreases reaction|increases transport | 11533133
|
D003847 |
Deoxyglucose |
FXYD2 protein results in increased transport of Deoxyglucose | increases transport | 11533133
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of FXYD2 mRNA | increases expression | 18035473
|
D007444 |
Inulin |
Calcium inhibits the reaction [FXYD2 protein results in increased transport of Inulin] | decreases reaction|increases transport | 11533133
|
D007444 |
Inulin |
FXYD2 protein results in increased transport of Inulin | increases transport | 11533133
|
D008345 |
Manganese |
Manganese results in increased expression of FXYD2 mRNA | increases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in increased expression of FXYD2 mRNA | increases expression | 17175027
|
D013095 |
Spermidine |
FXYD2 protein results in increased transport of Spermidine | increases transport | 11533133
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of FXYD2 mRNA | increases expression | 15953391
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FXYD2 mRNA | increases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.99 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.67 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.43 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.28 | 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
11.13 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
11.13 | 16910769 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.87 | 16835338 12569548 16251483 18414634 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.26 | 19371607 12928151 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.07 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.07 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Deoxyglucose |
2.07 | 18985042 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.61 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.24 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.24 | 17306315 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.74 | 18922899 15504454 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.74 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.10 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.47 | 15738583 19152805 17938729 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.33 | 16973168 18022660 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 12621046 15340226 15668235 8697196 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 15322242 20055451 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.54 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.41 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 15322242 18230668 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.01 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.99 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.62 | 6392382 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
3.93 | 17043766 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.49 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.49 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.93 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 16354765 8697196 18606429 16959395 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.48 | 17050553 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.26 | 16076760 11953799 9931084 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.26 | 18850075 18670907 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.62 | 16093927 |
MESH:C537152 |
Hypomagnesemia 2, renal |
marker/mechanism |
|
| |
MESH:C537153 |
Hypomagnesemia primary |
marker/mechanism |
|
| 11062458 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.04 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.04 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.04 | 16930632 12749816 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.11 | 16316344 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.57 | 17339181 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.55 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
10.79 | 2125692 18177683 9163691 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
10.79 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.79 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.86 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.86 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.87 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
4.87 | 17976673 19168569 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.87 | 18520028 20464547 20869020 18569708 20064080 18816296 17053015 20135361 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.87 | 11884234 19555203 |
MESH:D008275 |
Magnesium Deficiency |
marker/mechanism |
|
| 11062458 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
5.58 | 16568477 16551646 19453300 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
5.04 | 16551646 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.08 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.08 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.18 | 11141357 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.29 | 16551646 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.25 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
3.47 | 16620997 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.41 | 17056641 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.80 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
2.75 | 17306315 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.38 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.50 | 16140633 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.21 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.04 | 6392382 16905509 15371236 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.24 | 11222880 11118676 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.84 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.84 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Deoxyglucose |
2.84 | 18985042 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.04 | 21343184 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012640 |
Seizures |
|
Deoxyglucose |
4.62 | 17978042 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.75 | 17050553 19834688 17938729 6392382 18709164 16759981 16353154 16702368 17453740 15952646 17548696 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.51 | 17976673 16251483 17029826 19538983 17050553 15504454 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.51 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.51 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.20 | 19429237 11144890 18640142 19322015 17306315 15987713 17976673 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.20 | 17053015 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.79 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |